DISSEMINATED STRONGYLOIDIASIS IN A CHILD WITH LYMPHOBLASTIC LYMPHOMA

Purpose: This report describes a case of disseminated strongyloidiasis in a child receiving chemotherapy for T-cell lymphoblastic lymphoma. Patient and Methods: A 10-year-old boy became severely ill with dissem inated strongyloidiasis 4 weeks after starting chemotherapy for T-cell lymphoblastic lymphoma. He responded to treatment with supportive car e, antibiotics, and albendazole but required ivermectin to eradicate t he strongyloides infection. Conclusion: Disseminated strongyloidiasis is a severe, life-threatening complication of Strongyloides stercorali s infection that can occur in patients on immunosuppressive therapy, p articularly when this therapy includes corticosteriods. In endemic are as, screening patients due to undergo immunosuppressive treatment and appropriate antistrongyloides treatment may be life saving. Ivermectin is the treatment of choice.